By Editor , 15 September 2026
Tecnau, Sitma to Debut AutoSetup, CutReady at PRINTING United 2026

North Andover, Mass. – September 15, 2026 -- Tecnau and Sitma will present new print finishing and packaging automation technology at PRINTING United Expo 2026, running September 23-25 in Las Vegas, under the banner "From Print to Profit."

By Editor , 15 September 2026
SandboxAQ, Northrop Grumman Test MagNav on Attritable Drone

Palo Alto, Calif. – September 15, 2026 -- SandboxAQ has completed what it calls the world's first reported test of a magnetic navigation (MagNav) system on an attritable drone platform, integrating its AQNav software into Northrop Grumman's Lumberjack Group 3 unmanned aircraft system.

By Editor , 15 September 2026
Elbit Systems Rebrands U.S. Unit as Twenty-Six Defense

Fort Worth, Texas – September 15, 2026 -- Elbit Systems Ltd.'s U.S. operating segment will now operate as Twenty-Six Defense, a rebranding that reinforces the Israeli defense contractor's long-term commitment to domestic manufacturing amid U.S. government pressure to expand industrial capacity.

By Editor , 15 September 2026
Integrity Partners With Dallas-Based Brave Insurance Group

Dallas – September 15, 2026 -- Integrity, LLC has partnered with Brave Insurance Group, a Dallas-based independent marketing organization founded by Blake Naylor specializing in final expense insurance. Financial terms of the deal were not disclosed.

By Editor , 15 September 2026
Milagro Expands Autonomous Coding to 12 CSA Surgery Centers

Austin, Texas – September 15, 2026 -- Milagro has extended its autonomous surgical coding platform to three additional ambulatory surgery centers operated by Constitution Surgery Alliance (CSA), bringing total deployment to 12 CSA facilities across New England and the Northeast.

By Editor , 15 September 2026
EMD Serono Buys PostEra's AI-Designed Oral Fertility Drug Programs

Boston – September 15, 2026 -- EMD Serono, Inc., the healthcare business of Merck KGaA, Darmstadt, Germany, in the United States and Canada, has acquired two preclinical fertility drug programs from PostEra, a biotech firm built on artificial intelligence-driven small molecule discovery.

By Editor , 15 September 2026
EMD Serono Acquires PostEra's Oral Fertility Drug Programs

Boston – September 15, 2026 -- EMD Serono, Inc., the U.S. and Canada healthcare business of Merck KGaA, Darmstadt, Germany, has acquired two preclinical fertility drug programs from PostEra, a biotechnology company that uses artificial intelligence for small-molecule drug discovery.